Stuck at the border

On 24 April, the European Parliament’s foreign-policy committee delayed a vote on a trade deal with Israel, extending deliberations that began in May 2010. Here, a cross-party group of MEPs argues for immediate approval, while European critics of Israeli policies argue for the rejection of the agreement until Israel complies with international law.

The European Parliament was this week to have considered a practical issue for European citizens: a trade agreement that would facilitate the import of high-quality and affordable medicines into Europe. Many might reasonably think that the Parliament would be eager to ratify an agreement with clear benefits for European patients; the agreement has, instead, been politicised and the legislative process stalled for the past two years. 

Please log in to read this article:

Forgot your password? Click here

Don't have a login yet?

Register for free to read this article.
It only takes a minute.